NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $2.43 million. The enterprise value is $4.08 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 750,808 shares outstanding.
| Current Share Class | 730,281 |
| Shares Outstanding | 750,808 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +124.35% |
| Owned by Insiders (%) | 5.83% |
| Owned by Institutions (%) | 2.38% |
| Float | 707,017 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
| Current Ratio | 1.17 |
| Quick Ratio | 1.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.49 |
Financial Efficiency
Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -27.47%.
| Return on Equity (ROE) | -53.76% |
| Return on Assets (ROA) | -17.99% |
| Return on Invested Capital (ROIC) | -27.47% |
| Return on Capital Employed (ROCE) | -135.35% |
| Revenue Per Employee | $71,492 |
| Profits Per Employee | -$6,903 |
| Employee Count | 76 |
| Asset Turnover | 1.35 |
| Inventory Turnover | 34.83 |
Taxes
| Income Tax | -486,706 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.57% in the last 52 weeks. The beta is 0.25, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -98.57% |
| 50-Day Moving Average | 5.70 |
| 200-Day Moving Average | 84.07 |
| Relative Strength Index (RSI) | 38.42 |
| Average Volume (20 Days) | 536,070 |
Short Selling Information
The latest short interest is 48,859, so 6.51% of the outstanding shares have been sold short.
| Short Interest | 48,859 |
| Short Previous Month | 69,705 |
| Short % of Shares Out | 6.51% |
| Short % of Float | 6.91% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $5.43 million and -$524,643 in losses. Loss per share was -$14.65.
| Revenue | 5.43M |
| Gross Profit | 1.83M |
| Operating Income | -1.16M |
| Pretax Income | n/a |
| Net Income | -524,643 |
| EBITDA | -1.14M |
| EBIT | -1.16M |
| Loss Per Share | -$14.65 |
Full Income StatementBalance Sheet
The company has $1.53 million in cash and $3.18 million in debt, giving a net cash position of -$1.65 million or -$2.20 per share.
| Cash & Cash Equivalents | 1.53M |
| Total Debt | 3.18M |
| Net Cash | -1.65M |
| Net Cash Per Share | -$2.20 |
| Equity (Book Value) | -1.48M |
| Book Value Per Share | -9.21 |
| Working Capital | 452,391 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$53,045, giving a free cash flow of -$8.32 million.
| Operating Cash Flow | -8.26M |
| Capital Expenditures | -53,045 |
| Free Cash Flow | -8.32M |
| FCF Per Share | -$11.08 |
Full Cash Flow StatementMargins
Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.
| Gross Margin | 33.62% |
| Operating Margin | -21.36% |
| Pretax Margin | -17.68% |
| Profit Margin | -9.66% |
| EBITDA Margin | -21.00% |
| EBIT Margin | -21.36% |
| FCF Margin | n/a |